Explore

Streams

About Index

Index

By TNW

Pfizer

3815

Pfizer

Breakthroughs that change patients' lives

Type

B2b

Follow us

Also headquartered in New York

Alexa global traffic share

Twitter followers

Terms of Service Privacy Policy Cookie Statement

Built with ❤︎ by Datalicious ©2022
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

Investments 34

Team Size

1–10

Employees

Location

New York , United States

Headquarters

Explore New York

Older adults got higher omicron protection by switching from Pfizer to Moderna

Pfizer snaps up migraine drugmaker Biohaven for $11.6bn

,

Why Pfizer (PFE) Is Buying Biohaven Pharmaceutical (BHVN) For $11.6 Billion In Cash

Pfizer profits breeze past Wall Street expectations

FDA lifts Pfizer gene therapy clinical hold, but trial adds new safety measures

Biohaven migraine drug partnered with Pfizer lands twin European approvals

Pfizer Recalls Some Batches of Its Blood Pressure Medication

Covid-19 booster raises antibody levels against Omicron for children ages 5 through 11, Pfizer and BioNTech say

Pfizer (PFE) Stock: $75 Price Target And Overweight Rating

Pfizer (PFE) Stock: $55 Price Target And Equal-Weight Rating

Pfizer (PFE) Stock: $57 Price Target From Citi

,

Why Pfizer (PFE) Is Buying ReViral For Up To $525 Million

Pfizer (PFE) Stock: Why The Price Increased Today

Pfizer, Moderna vaccines spur slightly different antibodies, study finds

Data and regulatory roundup: Pfizer’s feat, an ADHD miss, Eli Lilly’s CRL & more

AN2 Therapeutics’ IPO raises $69M to take antibiotic from Pfizer into pivotal test

Pfizer CEO pushes annual Covid shot, but experts disagree

Alnylam sues Moderna & Pfizer, claiming Covid-19 vaccines infringe lipid patent

Pfizer Asks FDA to Authorize Extra COVID Booster for Older Adults

Pfizer Pushes for 4th COVID-19 Vaccine Dose: Is This for Life After the Pandemic?